Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shawn Singh Insider Profile
11 Followers
Shawn Singh, CEO, Director at VistaGen Therapeutics, holds 31.36K shares in VistaGen Therapeutics (Ticker: VTGN), holds 625.91K shares in Echo Therapeutics (Ticker: ECTE).
Shawn Singh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Shawn Singh holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 18, 2022 - Aug 18, 2023
Return:-17.90%
The most profitable trade made by Shawn Singh
Shawn Singh's Trading History
VistaGen Therapeutics
Jul 02, 2024
CEO, Director
Uninformative Buy
14.32K
$80.91K
Echo Therapeutics
―
―
―
$18.78K
List of latest transactions for each holding click on a transaction to see Shawn Singh's performance on stock
You May Also Like
Shawn Singh insider profile FAQ
What is the percentage of profitable transactions made by Shawn Singh?
The percentage of profitable transactions made by Shawn Singh is ―.
What is the average return per transaction made by Shawn Singh?
The average return per transaction made by Shawn Singh is ―.
What stocks does Shawn Singh hold?
Shawn Singh holds: VTGN, ECTE stocks.
What was Shawn Singh’s latest transaction?
Shawn Singh latest transaction was an Uninformative Buy of $14.32K.
What was Shawn Singh's most profitable transaction?
Shawn Singh’s most profitable transaction was an Informative Buy of VTGN stock on August 18, 2022. The return on the trade was -17.90%.
What is Shawn Singh's role in VistaGen Therapeutics?
Shawn Singh's role in VistaGen Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.